Neurocrine Biosciences Inc
SWB:NB3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Neurocrine Biosciences Inc
SWB:NB3
|
US |
|
Boston Scientific Corp
NYSE:BSX
|
US |
|
Alimentation Couche-Tard Inc
F:CJA1
|
CA |
|
Schindler Holding AG
SIX:SCHP
|
CH |
|
A
|
Aptose Biosciences Inc
NASDAQ:APTO
|
CA |
|
ITEQ Corp
TWSE:6213
|
TW |
|
Biotest AG
F:BIO3
|
DE |
|
V
|
Vanda Pharmaceuticals Inc
XBER:VM4
|
US |
|
S
|
Snap Inc
F:1SI
|
US |
|
Elgi Equipments Ltd
BSE:522074
|
IN |
|
Prakash Pipes Ltd
NSE:PPL
|
IN |
|
Fidus Investment Corp
NASDAQ:FDUS
|
US |
|
S
|
SCB X PCL
SET:SCB
|
TH |
|
V
|
VOXX International Corp
F:VOX
|
US |
|
A
|
Andritz AG
DUS:AZ2
|
AT |
|
E
|
Equifax Inc
XMUN:EFX
|
US |
|
R
|
Rusta AB (publ)
STO:RUSTA
|
SE |
|
Synopsys Inc
NASDAQ:SNPS
|
US |
|
T
|
Tantalus Systems Holding Inc
TSX:GRID
|
CA |
|
LVMH Moet Hennessy Louis Vuitton SE
F:MOH
|
FR |
|
B
|
Beneteau SA
XBER:3GD
|
FR |
|
Argo Blockchain PLC
F:0XP
|
UK |
|
N
|
Novo Nordisk A/S
SWB:NOVA
|
DK |
|
Yankuang Energy Group Co Ltd
F:YZCA
|
CN |
Shareholder Yield
Current shareholder yield for 
NB3 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
NB3 Price
Neurocrine Biosciences Inc
| Average Annual Return | 16.29% |
| Standard Deviation of Annual Returns | 18.67% |
| Max Drawdown | -47% |
| Market Capitalization | 15.8B EUR |
| Shares Outstanding | 56 628 781 |
| Percentage of Shares Shorted |
N/A
|
